Home LiteratureArticle Details
PMID: 12605717 Published · epublish English Journal Article Review

Invasion and metastasis in pancreatic cancer.

Molecular cancer ·Vol. 2 ·2003-01-22 ·Pages 14

Keleg S, Büchler P, Ludwig R, Büchler MW, Friess H

Abstract

Pancreatic cancer remains a challenging disease with an overall cumulative 5-year survival rate below 1%. The process of cancer initiation, progression and metastasis is still not understood well. Invasion and tumor metastasis are closely related and both occur within a tumour-host microecology, where stroma and tumour cells exchange enzymes and cytokines that modify the local extracellular matrix, stimulate cell migration, and promote cell proliferation and tumor cell survival. During the last decade considerable progress has been made in understanding genetic alterations of genes involved in local and systemic tumor growth. The most important changes occur in genes which regulate cell cycle progression, extracellular matrix homeostasis and cell migration. Furthermore, there is growing evidence that epigenetic factors including angiogenesis and lymphangiogenesis may participate in the formation of tumor metastasis. In this review we highlight the most important genetic alterations involved in tumor invasion and metastasis and further outline the role of tumor angiogenesis and lymphangiogenesis in systemic tumor dissemination.

MeSH Terms
Animals Cell Adhesion Molecules/metabolism Disease Progression Genes, Tumor Suppressor Humans Loss of Heterozygosity Neoplasm Invasiveness Neoplasm Metastasis Pancreatic Neoplasms/genetics,metabolism,pathology
Chemicals
Cell Adhesion Molecules
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Keleg Shereen
University of Heidelberg, Department of Surgery, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany. [email protected]
Büchler Peter
Ludwig Roman
Büchler Markus W
Friess Helmut
References (60)
60 references, click to expand
  1. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells.
    Cancer Res. 2001 Jul 1;61(13):5284-8 PMID: 11431371
  2. Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage.
    J Clin Oncol. 2001 May 1;19(9):2422-32 PMID: 11331321
  3. Adhesion molecules in human pancreatic cancer.
    J Surg Oncol. 2002 Feb;79(2):93-100 PMID: 11815996
  4. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis.
    Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2193-8 PMID: 11854515
  5. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
    Anticancer Res. 2001 Nov-Dec;21(6A):4127-34 PMID: 11911306
  6. Lymphatic metastasis in the absence of functional intratumor lymphatics.
    Science. 2002 Jun 7;296(5574):1883-6 PMID: 11976409
  7. Lymphangiogenesis and cancer metastasis.
    Nat Rev Cancer. 2002 Aug;2(8):573-83 PMID: 12154350
  8. Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials.
    Ann Surg Oncol. 2002 Aug;9(7):668-74 PMID: 12167581
  9. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.
    J Surg Oncol. 2002 Jun;80(2):105-10 PMID: 12173379
  10. Identification of rat pancreatic carcinoma genes associated with lymphogenous metastasis.
    Anticancer Res. 2002 Jul-Aug;22(4):2015-27 PMID: 12174879
  11. VEGF-RII influences the prognosis of pancreatic cancer.
    Ann Surg. 2002 Dec;236(6):738-49; discussion 749 PMID: 12454512
  12. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.
    Nature. 1983 Oct 27-Nov 2;305(5937):779-84 PMID: 6633649
  13. Plasminogen activators, tissue degradation, and cancer.
    Adv Cancer Res. 1985;44:139-266 PMID: 2930999
  14. Cancer. Gene losses in human tumours.
    Nature. 1988 Sep 29;335(6189):400-2 PMID: 3419514
  15. Molecular themes in oncogenesis.
    Cell. 1991 Jan 25;64(2):235-48 PMID: 1988146
  16. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.
    Cell. 1991 Apr 5;65(1):25-35 PMID: 2013093
  17. Tumor-associated urokinase-type plasminogen activator: biological and clinical significance.
    Biol Chem Hoppe Seyler. 1992 Jul;373(7):611-22 PMID: 1515091
  18. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.
    Nature. 1993 Apr 29;362(6423):841-4 PMID: 7683111
  19. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage.
    Cancer Res. 1993 Nov 1;53(21):5289-96 PMID: 7693336
  20. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
    Nature. 1994 Feb 10;367(6463):576-9 PMID: 8107827
  21. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2.
    Science. 1995 May 12;268(5212):884-6 PMID: 7754374
  22. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
    Int J Cancer. 1995 Aug 9;62(4):407-13 PMID: 7635566
  23. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.
    Nat Med. 1995 Feb;1(2):149-53 PMID: 7585012
  24. Life (and death) in a malignant tumour.
    Nature. 1996 Jan 4;379(6560):19-20 PMID: 8538735
  25. Integrin alpha3beta1 can promote adhesion and spreading of metastatic breast carcinoma cells on the lymph node stroma.
    Int J Cancer. 1996 May 29;66(5):703-10 PMID: 8647636
  26. How tumors become angiogenic.
    Adv Cancer Res. 1996;69:135-74 PMID: 8791681
  27. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases.
    Cancer Res. 1996 Nov 1;56(21):4876-80 PMID: 8895737
  28. Integrins and cancer.
    Curr Opin Cell Biol. 1996 Oct;8(5):724-30 PMID: 8939661
  29. Matrix metalloproteinases and the development of cancer.
    Chem Biol. 1996 Nov;3(11):895-904 PMID: 8939708
  30. Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
    Br J Cancer. 1997;75(3):388-95 PMID: 9020484
  31. Genomic organization of the human KAI1 metastasis-suppressor gene.
    Genomics. 1997 Apr 1;41(1):25-32 PMID: 9126478
  32. Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias.
    Anticancer Res. 1997 Mar-Apr;17(2B):1227-30 PMID: 9137477
  33. Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis.
    Gastroenterology. 1997 Sep;113(3):904-13 PMID: 9287983
  34. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma.
    J Pathol. 1997 Jul;182(3):347-55 PMID: 9349239
  35. KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers.
    Cancer Res. 1998 Feb 15;58(4):753-8 PMID: 9485031
  36. Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer.
    Int J Cancer. 1998 Feb 20;79(1):76-81 PMID: 9495363
  37. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas.
    Am J Surg Pathol. 1998 Feb;22(2):163-9 PMID: 9500216
  38. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
    Cancer Res. 1998 Apr 1;58(7):1408-16 PMID: 9537241
  39. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins.
    Pharmacol Rev. 1998 Jun;50(2):197-263 PMID: 9647866
  40. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
    Am J Pathol. 1998 Jul;153(1):201-12 PMID: 9665481
  41. Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases.
    Int J Cancer. 1998 Aug 21;79(4):349-55 PMID: 9699525
  42. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay.
    Cell. 1998 Aug 7;94(3):353-62 PMID: 9708737
  43. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
    Hepatology. 1998 Dec;28(6):1481-8 PMID: 9828210
  44. Matrix metalloproteinases generate angiostatin: effects on neovascularization.
    J Immunol. 1998 Dec 15;161(12):6845-52 PMID: 9862716
  45. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene.
    Trends Biochem Sci. 1999 Feb;24(2):73-6 PMID: 10098402
  46. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.
    Science. 1999 Apr 30;284(5415):808-12 PMID: 10221914
  47. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.
    J Clin Invest. 1999 May;103(9):1237-41 PMID: 10225966
  48. Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression.
    Clin Cancer Res. 1999 May;5(5):1125-30 PMID: 10353747
  49. Matrix metalloproteinases and metastasis.
    Cancer Chemother Pharmacol. 1999;43 Suppl:S42-51 PMID: 10357558
  50. Adhesion molecules.
    Cancer Treat Res. 2002;107:305-29 PMID: 11775459
  51. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association.
    Gastroenterology. 1999 Dec;117(6):1464-84 PMID: 10579989
  52. The hallmarks of cancer.
    Cell. 2000 Jan 7;100(1):57-70 PMID: 10647931
  53. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice.
    J Clin Invest. 2000 Apr;105(8):1045-7 PMID: 10772648
  54. Inverse correlation between KAI1 mRNA levels and invasive behaviour in bladder cancer cell lines.
    Cancer Lett. 2000 Aug 1;156(1):9-17 PMID: 10840154
  55. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin.
    Ann N Y Acad Sci. 2000 May;902:249-62; discussion 262-4 PMID: 10865845
  56. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.
    Nat Cell Biol. 2000 Oct;2(10):737-44 PMID: 11025665
  57. The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis.
    Med Res Rev. 2001 Mar;21(2):146-70 PMID: 11223863
  58. Involvement of chemokine receptors in breast cancer metastasis.
    Nature. 2001 Mar 1;410(6824):50-6 PMID: 11242036
  59. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
    EMBO J. 2001 Mar 15;20(6):1223-31 PMID: 11250889
  60. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
    Lancet. 2001 Nov 10;358(9293):1576-85 PMID: 11716884
Article Info
Journal
Molecular cancer
Abbr.
Mol Cancer
ISSN
1476-4598
Published
2003-01-22
Epub
2003-00-22
Pages
14
Language
English
Region
England
NLM ID
101147698
PMCID
PMC149416
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]